BABIO Introduces Rapid Typhoid IgG/IgM Test Kit for Reliable Point-of-Care Diagnostics

BABIO Introduces Rapid Typhoid IgG/IgM Test Kit for Reliable Point-of-Care Diagnostics

Qingdao, China – May 2025 — As the global healthcare community continues to combat infectious diseases in both endemic and travel-associated cases, BABIO Biotechnology, a renowned Chinese manufacturer of in vitro diagnostic products, has launched its advanced Typhoid IgG/IgM Test Kit (Colloidal Gold Method). This rapid and user-friendly kit allows healthcare professionals to quickly detect and differentiate IgG and IgM antibodies to Salmonella typhi in human serum, plasma, or whole blood.

Designed for use in clinical laboratories, hospitals, field settings, and point-of-care scenarios, this kit empowers early diagnosis and effective monitoring of typhoid fever, particularly in resource-limited and high-prevalence regions.

 What Does the BABIO Typhoid IgG/IgM Test Do?

The BABIO® Typhoid IgG/IgM Test Kit is a chromatographic immunoassay that utilizes the colloidal gold method to deliver qualitative results within 10–20 minutes. It identifies specific immune responses (IgG and/or IgM antibodies) to Salmonella typhi, offering insights into whether an infection is current, latent, or indicates past exposure.

 Key Features & Benefits

• Dual Antibody Detection: Distinguishes between IgM (recent infection) and IgG (past or chronic infection).

• Fast Results: Results in as little as 10 minutes, enabling rapid clinical decisions.

• User-Friendly Protocol: Simple test procedure with minimal training required.

• Minimal Sample Requirement: Only 35 µL of serum, plasma, or whole blood needed.

• Clear Interpretation: Easily distinguishable test lines for IgM, IgG, and control validation.

 Clinical Significance

• IgM Positive: Indicates acute or recent typhoid infection.

• IgG Positive: Suggests past infection or carrier state.

• IgM & IgG Positive: Reflects ongoing or recurring infection.

• Negative: No detectable antibodies; however, further molecular testing is advised if clinical suspicion remains high.

For Use In:

• Hospitals and outpatient clinics

• Travel medicine and infectious disease units

• Mobile labs and field investigations

• Health screening in typhoid-endemic regions

• Laboratories requiring quick serological evidence for S. typhi infection

Important Limitations

While the BABIO Typhoid IgG/IgM kit is highly specific and sensitive, it is a qualitative test and should be interpreted alongside clinical history and additional lab findings. Negative results do not rule out infection, especially in early-stage cases. Confirmatory molecular testing is recommended when necessary.

 Why Choose BABIO?

BABIO Biotechnology is a trusted China-based diagnostic manufacturer, recognized globally for delivering high-quality, CE-certified medical diagnostic tools. Our products are exported to Europe, Asia, Africa, and the Americas, supporting global healthcare initiatives through innovation, affordability, and reliability.

Learn More or Request Samples

To request free samples, obtain technical details, or inquire about OEM/ODM services, please visit: https://www.babiocorp.com

#TyphoidTest

#IgGIgMTest

#PointOfCareDiagnostics

#BABIOBiotech

#RapidTestKit

#SalmonellaTyphi

#TyphoidFever

#InVitroDiagnostics

#MedicalSupplies

#GlobalHealth